News & Updates
Filter by Specialty:

Cytisine on par with nortriptyline for smoking cessation
Treatment with cytisine shows comparable efficacy to that of nortriptyline for smoking cessation at 1 year, according to a study. In addition, adverse events for both medications are few and well-tolerated.
Cytisine on par with nortriptyline for smoking cessation
30 Sep 2024
Benralizumab offers sustained remission in severe eosinophilic asthma
Treatment with benralizumab (BRZ) results in sustained remission in patients with severe eosinophilic asthma (SEA), particularly those with comorbid chronic rhinosinusitis with nasal polyps (CRSwNP) and reversible airflow limitation, reports a study.
Benralizumab offers sustained remission in severe eosinophilic asthma
30 Sep 2024
Autism risk in children not heightened by COVID-19 pandemic exposure
Children born during the COVID-19 pandemic or to mothers with history of prenatal SARS-CoV-2 infection are not at increased risk of autism compared with their counterparts who were born before the pandemic or have no exposure to maternal SARS-CoV-2 infection, as reported in a cohort study.
Autism risk in children not heightened by COVID-19 pandemic exposure
29 Sep 2024
Long-term bulevirtide use safe, efficacious in chronic HDV
Longer treatment with bulevirtide (BLV) monotherapy in patients with chronic hepatitis delta (CHD) for 96 weeks results in sustained or continued improvements in virologic, biochemical, and combined responses, a study has shown.